INS and chronic kidney disease: Time to close the AG was significantly shorter among patients with normal kidney function who received an insulin subcutaneous dose with a mean of 11.2 ± 10.2 hours compared to 26.9 ± 19.3 hours for patients with CKD (MD 15.7 ± 16.8 hours, p=0.045).